Your browser doesn't support javascript.
loading
Long-term HIV Pre-exposure Prophylaxis Trajectories Among Racial & Ethnic Minority Patients: Short, Declining, & Sustained Adherence.
Pyra, Maria; Brewer, Russell; Rusie, Laura; Kline, Jeanelle; Willis, India; Schneider, John.
Afiliação
  • Pyra M; Howard Brown Health, Chicago IL; and.
  • Brewer R; Department of Medicine, University of Chicago, Chicago IL.
  • Rusie L; Department of Medicine, University of Chicago, Chicago IL.
  • Kline J; Howard Brown Health, Chicago IL; and.
  • Willis I; Howard Brown Health, Chicago IL; and.
  • Schneider J; Howard Brown Health, Chicago IL; and.
J Acquir Immune Defic Syndr ; 89(2): 166-171, 2022 02 01.
Article em En | MEDLINE | ID: mdl-34636809
ABSTRACT

BACKGROUND:

HIV pre-exposure prophylaxis (PrEP) requires continued use at an effective dosage to reduce HIV incidence. Data suggest early PrEP drop-off among many populations. We sought to describe PrEP use over the first year among racial and ethnic minority patients in the US.

SETTING:

Racial and ethnic minority patients initiating PrEP at a federally qualified health center in Chicago, IL.

METHODS:

Using electronic health records, we determined the adherence (≥6 weekly doses) trajectories over the first year of PrEP use and compared baseline and time-varying patient characteristics.

RESULTS:

From 2159 patients, we identified 3 PrEP use trajectories. Sustained use was the most common (40%) trajectory, followed by short use (30%) and declining use (29%). In adjusted models, younger age, Black race, as well as gender, sexual orientation, insurance status at baseline, and neighborhood were associated with trajectory assignment; within some trajectories, insurance status during follow-up was associated with odds of monthly adherence (≥6 weekly doses).

CONCLUSION:

Among racial and ethnic minorities, a plurality achieved sustained PrEP persistence. Access to clinics, insurance, and intersectional stigmas may be modifiable barriers to effective PrEP persistence; in addition, focus on younger users and beyond gay, cismale populations are needed.
Assuntos

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Fármacos Anti-HIV / Profilaxia Pré-Exposição / Minorias Sexuais e de Gênero Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: En Revista: J Acquir Immune Defic Syndr Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Fármacos Anti-HIV / Profilaxia Pré-Exposição / Minorias Sexuais e de Gênero Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: En Revista: J Acquir Immune Defic Syndr Ano de publicação: 2022 Tipo de documento: Article